IsoRay, Inc. Gains 34.43%
Wed 08 Jan 20 at 05:30 PM
IsoRay, Inc. (ISR:NYSEMKT) soared at $0.82, representing a gain of 34.4%. From Mon 16 Dec 19, the stock recorded 42.86% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About IsoRay, Inc. (ISR:NYSEMKT)
IsoRay Inc designs and develops personalized brachytherapy products. The company treats prostate cancer, brain, liver, breast cancer, colorectal cancer, gynecological cancer, lung cancer, ocular melanoma and pancreatic cancer.
Top 10 Gainers:
- ShiftPixy, Inc. (PIXY:NASDAQ), 148.71%
- Midatech Pharma plc (MTP:NASDAQ), 52.65%
- ToughBuilt Industries, Inc. (TBLT:NASDAQ), 45.72%
- ECMOHO Limited (MOHO:NASDAQ), 41.69%
- Verastem, Inc. (VSTM:NASDAQ), 36.51%
- Applied Therapeutics, Inc. (APLT:NASDAQ), 34.48%
- IsoRay, Inc. (ISR:NYSEMKT), 34.43%
- Wah Fu Education Group Limited (WAFU:NASDAQ), 33.53%
- Summer Infant, Inc. (SUMR:NASDAQ), 31.38%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 31.09%